354 related articles for article (PubMed ID: 18718350)
1. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
[TBL] [Abstract][Full Text] [Related]
2. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
[TBL] [Abstract][Full Text] [Related]
3. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
4. The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
Glasauer S; Rössert C; Strupp M
Ann N Y Acad Sci; 2011 Sep; 1233():162-7. PubMed ID: 21950989
[TBL] [Abstract][Full Text] [Related]
5. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological advances in the treatment of neuro-otological and eye movement disorders.
Strupp M; Brandt T
Curr Opin Neurol; 2006 Feb; 19(1):33-40. PubMed ID: 16415675
[TBL] [Abstract][Full Text] [Related]
7. Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders.
Kalla R; Strupp M
Curr Neuropharmacol; 2019; 17(1):7-13. PubMed ID: 30182858
[TBL] [Abstract][Full Text] [Related]
8. Modelling drug modulation of nystagmus.
Glasauer S; Rössert C
Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
[TBL] [Abstract][Full Text] [Related]
9. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus.
Hüfner K; Stephan T; Kalla R; Deutschländer A; Wagner J; Holtmannspötter M; Schulte-Altedorneburg G; Strupp M; Brandt T; Glasauer S
Neurology; 2007 Sep; 69(11):1128-35. PubMed ID: 17846412
[TBL] [Abstract][Full Text] [Related]
12. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
[TBL] [Abstract][Full Text] [Related]
13. Vertical nystagmus: clinical facts and hypotheses.
Pierrot-Deseilligny C; Milea D
Brain; 2005 Jun; 128(Pt 6):1237-46. PubMed ID: 15872015
[TBL] [Abstract][Full Text] [Related]
14. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
[TBL] [Abstract][Full Text] [Related]
15. What can acquired nystagmus tell us about congenital forms of nystagmus?
Leigh RJ; Khanna S
Semin Ophthalmol; 2006; 21(2):83-6. PubMed ID: 16702074
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of vestibular disorders and nystagmus.
Strupp M; Kremmyda O; Brandt T
Semin Neurol; 2013 Jul; 33(3):286-96. PubMed ID: 24057832
[TBL] [Abstract][Full Text] [Related]
17. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
[TBL] [Abstract][Full Text] [Related]
18. Aminopyridines for the treatment of neurologic disorders.
Strupp M; Teufel J; Zwergal A; Schniepp R; Khodakhah K; Feil K
Neurol Clin Pract; 2017 Feb; 7(1):65-76. PubMed ID: 28243504
[TBL] [Abstract][Full Text] [Related]
19. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
Glasauer S; Kalla R; Büttner U; Strupp M; Brandt T
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):451-3. PubMed ID: 15716550
[TBL] [Abstract][Full Text] [Related]
20. Prolonged asymmetric smooth-pursuit stimulation leads to downbeat nystagmus in healthy human subjects.
Marti S; Bockisch CJ; Straumann D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):143-9. PubMed ID: 15623767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
